Assessing the representativeness of trial populations for contemporary real-world cancer patients: A case study of adjuvant chemotherapy for colon cancer.

Authors

null

Jennifer Leigh Lund

University of North Carolina at Chapel Hill, Chapel Hill, NC

Jennifer Leigh Lund, Michael Webster-Clark, Emily W. Bratton

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Experience; Quality, Safety, and Implementation Science; Technology and Innovation in Quality of Care

Track

Technology and Innovation in Quality of Care,Patient Experience,Quality, Safety, and Implementation Science,Cost, Value, and Policy,Health Care Access, Equity, and Disparities

Sub Track

Real-World Evidence

Citation

J Clin Oncol 39, 2021 (suppl 28; abstr 306)

DOI

10.1200/JCO.2020.39.28_suppl.306

Abstract #

306

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Changes in prescribing patterns in stage III colon cancer (CC) since the IDEA collaboration.

Changes in prescribing patterns in stage III colon cancer (CC) since the IDEA collaboration.

First Author: Daniel Walden

First Author: Suganija Lakkunarajah

First Author: Praveen Ramakrishnan Geethakumari